Methods of treating cancer comprising targeting NQO1
- David A. Boothman
- Jinming Gao
- Ying Dong
- Erik Bey
Publication date
September 2011
DOI Publisher
United States Patent and Trademark OfficeAbstract
Disclosed herein are methods for determining whether an individual with cancer is suitable for a treatment with an NQO1 bioactivatable drug, predicting responsiveness of an individual with cancer to a treatment with an NQO1 bioactivatable drug, and treating an individual with cancer with an NQO1 bioactivatable drug composition.Board of Regents, University of Texas Syste
Add to ORKG